Global Surgical Hemostat Market Overview

The Surgical Hemostat Market is expected to grow at a significant growth rate, and the analysis period is 2022-2028, considering the base year as 2021.

The disruption of blood arteries that occurs during surgical procedures might result in loss of blood. In order to prevent an excessive amount of blood loss, it is essential to coagulate the blood. Hemostasis is the medical term describing the process of blood clots forming at the site of an injury. Hemostats are instruments that are deployed in the operating room to stem the flow of blood from the patient during surgical procedures. These devices assist in the formation of temporary blood clots, which are used to control bleeding. Nevertheless, it is essential that the utilization of these instruments be confined to specific areas and strictly governed.

 A significant rise in the number of surgical procedures being performed around the world is being fueled in large part by the rising prevalence of cardiovascular illnesses and other long-term conditions, such as cancer. The increase in the number of surgical procedures performed all over the world is anticipated to be a factor that will benefit the development of the global hemostats market in the years to come. Controlling complex bleeding during surgical procedures, in order to keep the patient safe and out of danger, is one of the applications that finds use for the products and solutions that are available on the worldwide hemostats market. Two of the most important factors driving the expansion of the Surgical Hemostats Market are the growing number of healthcare infrastructures and facilities that are opening around the world and the rising demand for a variety of surgical operations.

Market Dynamics And Factors For Surgical Hemostat Market

Drivers:

• The Increase in Research & Development Activities and Growing Awareness

Restraints:

• The Scarcity of Skilled Professionals and Trained Expertise

Opportunity:

• Government Investments for Healthcare Interoperability

Regional Analysis In Surgical Hemostat Market

The increasing number of surgical procedures performed, the increased focus on R &D, the rising prevalence of sports-related injuries and spinal disorders, and the expanding emphasis on effective blood loss control in patients during surgeries are expected to promote the growth rate of the North American Surgical Hemostat market. Moreover, North America was responsible for the biggest share in recent years. This pattern can be explained by a number of compelling factors, such as the early adoption of a variety of technologically enhanced medical products and solutions in the regional healthcare infrastructure as well as the rising demand for effective hemostat solutions in the region over the course of the last few years and there are major players present in North America.

Covid-19 Impact Analysis On Surgical Hemostat Market

Established pharmaceutical and biopharmaceutical businesses, as well as small startups, have banded together in response to the World Health Organization's declaration of the COVID-19 outbreak as a pandemic to create therapies and vaccines specific to the infection caused by the novel coronavirus. The global spread of COVID-19 has had a major effect on the number of available medical facilities and personnel. The primary response to this problem has been the implementation of infection prevention and control measures, as well as the significant reduction of inpatient and outpatient care for other disorders. As the virus spread across the globe, fewer people were able to have surgery.

Top Key Players Covered In Surgical Hemostat Market

• CR Bard Inc. (United States)
• B. Braun Melsungen AG (Germany)
• Baxter International Inc. (United States)
• Integra LifeSciences (United States)
• Marine Polymer Technologies, Inc. (United States)
• Teleflex (United States)
• Ethicon Inc. (United States)
• Pfizer Inc. (United States)
• Z-Medica LLC (United States)
• Gelita Medical GmbH (Germany)
• Anika Therapeutics Inc. (United States)
• Stryker (United States)
• Integra Lifesciences Corporation (United States), and Other Major Players

Key Industry Development In The Surgical Hemostat Market

In February 2021, EndoClot Plus, Inc., announced that the company had received clearance for EndoClot Polysaccharide Hemostatic System from the U.S. Food and Drug Administration (FDA). This innovative product helps gastroenterologists to prevent bleeding rapidly. This technology represents a significant milestone in advancing the care of the G.I. patient.

In July 2021, Medcura, Inc., a medical device company together with ASO LLC, announced the launch of a new class of antibacterial hemostatic gel, Rapid-Seal. This product meets the market demand for a transparent gel that will be easily applied to injuries.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Surgical Hemostat Market by Product Type
 5.1 Surgical Hemostat Market Overview Snapshot and Growth Engine
 5.2 Surgical Hemostat Market Overview
 5.3 Thrombin Based
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Thrombin Based: Geographic Segmentation
 5.4 Oxidized Regenerated Cellulose Based
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Oxidized Regenerated Cellulose Based: Geographic Segmentation
 5.5 Gelatin Based
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Gelatin Based: Geographic Segmentation
 5.6 Collagen Based Hemostat
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Collagen Based Hemostat: Geographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Geographic Segmentation

Chapter 6: Surgical Hemostat Market by Application
 6.1 Surgical Hemostat Market Overview Snapshot and Growth Engine
 6.2 Surgical Hemostat Market Overview
 6.3 Neurological Surgery
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Neurological Surgery: Geographic Segmentation
 6.4 Cardiovascular Surgery
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Cardiovascular Surgery: Geographic Segmentation
 6.5 Reconstructive Surgery
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Reconstructive Surgery: Geographic Segmentation
 6.6 Gynecological Surgery
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Gynecological Surgery: Geographic Segmentation
 6.7 Others
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Others: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 Surgical Hemostat Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Surgical Hemostat Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 Surgical Hemostat Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 CR BARD INC. (UNITED STATES)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 B. BRAUN MELSUNGEN AG (GERMANY)
 7.4 BAXTER INTERNATIONAL INC. (UNITED STATES)
 7.5 INTEGRA LIFESCIENCES (UNITED STATES)
 7.6 MARINE POLYMER TECHNOLOGIES INC. (UNITED STATES)
 7.7 TELEFLEX (UNITED STATES)
 7.8 ETHICON INC. (UNITED STATES)
 7.9 PFIZER INC. (UNITED STATES)
 7.10 Z-MEDICA LLC (UNITED STATES)
 7.11 GELITA MEDICAL GMBH (GERMANY)
 7.12 ANIKA THERAPEUTICS INC. (UNITED STATES)
 7.13 STRYKER (UNITED STATES)
 7.14 INTEGRA LIFESCIENCES CORPORATION (UNITED STATES)
 7.15 OTHER MAJOR PLAYERS

Chapter 8: Global Surgical Hemostat Market Analysis, Insights and Forecast, 2016-2028
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Product Type
  8.2.1 Thrombin Based
  8.2.2 Oxidized Regenerated Cellulose Based
  8.2.3 Gelatin Based
  8.2.4 Collagen Based Hemostat
  8.2.5 Others
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Neurological Surgery
  8.3.2 Cardiovascular Surgery
  8.3.3 Reconstructive Surgery
  8.3.4 Gynecological Surgery
  8.3.5 Others

Chapter 9: North America Surgical Hemostat Market Analysis, Insights and Forecast, 2016-2028
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Product Type
  9.4.1 Thrombin Based
  9.4.2 Oxidized Regenerated Cellulose Based
  9.4.3 Gelatin Based
  9.4.4 Collagen Based Hemostat
  9.4.5 Others
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Neurological Surgery
  9.5.2 Cardiovascular Surgery
  9.5.3 Reconstructive Surgery
  9.5.4 Gynecological Surgery
  9.5.5 Others
 9.6 Historic and Forecast Market Size by Country
  9.6.1 U.S.
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Europe Surgical Hemostat Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product Type
  10.4.1 Thrombin Based
  10.4.2 Oxidized Regenerated Cellulose Based
  10.4.3 Gelatin Based
  10.4.4 Collagen Based Hemostat
  10.4.5 Others
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Neurological Surgery
  10.5.2 Cardiovascular Surgery
  10.5.3 Reconstructive Surgery
  10.5.4 Gynecological Surgery
  10.5.5 Others
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Germany
  10.6.2 U.K.
  10.6.3 France
  10.6.4 Italy
  10.6.5 Russia
  10.6.6 Spain
  10.6.7 Rest of Europe

Chapter 11: Asia-Pacific Surgical Hemostat Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product Type
  11.4.1 Thrombin Based
  11.4.2 Oxidized Regenerated Cellulose Based
  11.4.3 Gelatin Based
  11.4.4 Collagen Based Hemostat
  11.4.5 Others
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Neurological Surgery
  11.5.2 Cardiovascular Surgery
  11.5.3 Reconstructive Surgery
  11.5.4 Gynecological Surgery
  11.5.5 Others
 11.6 Historic and Forecast Market Size by Country
  11.6.1 China
  11.6.2 India
  11.6.3 Japan
  11.6.4 Singapore
  11.6.5 Australia
  11.6.6 New Zealand
  11.6.7 Rest of APAC

Chapter 12: Middle East & Africa Surgical Hemostat Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product Type
  12.4.1 Thrombin Based
  12.4.2 Oxidized Regenerated Cellulose Based
  12.4.3 Gelatin Based
  12.4.4 Collagen Based Hemostat
  12.4.5 Others
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Neurological Surgery
  12.5.2 Cardiovascular Surgery
  12.5.3 Reconstructive Surgery
  12.5.4 Gynecological Surgery
  12.5.5 Others
 12.6 Historic and Forecast Market Size by Country
  12.6.1 Turkey
  12.6.2 Saudi Arabia
  12.6.3 Iran
  12.6.4 UAE
  12.6.5 Africa
  12.6.6 Rest of MEA

Chapter 13: South America Surgical Hemostat Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product Type
  13.4.1 Thrombin Based
  13.4.2 Oxidized Regenerated Cellulose Based
  13.4.3 Gelatin Based
  13.4.4 Collagen Based Hemostat
  13.4.5 Others
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Neurological Surgery
  13.5.2 Cardiovascular Surgery
  13.5.3 Reconstructive Surgery
  13.5.4 Gynecological Surgery
  13.5.5 Others
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Brazil
  13.6.2 Argentina
  13.6.3 Rest of SA

Chapter 14 Investment Analysis

Chapter 15 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SURGICAL HEMOSTAT MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SURGICAL HEMOSTAT MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SURGICAL HEMOSTAT MARKET COMPETITIVE RIVALRY
TABLE 005. SURGICAL HEMOSTAT MARKET THREAT OF NEW ENTRANTS
TABLE 006. SURGICAL HEMOSTAT MARKET THREAT OF SUBSTITUTES
TABLE 007. SURGICAL HEMOSTAT MARKET BY PRODUCT TYPE
TABLE 008. THROMBIN BASED MARKET OVERVIEW (2016-2028)
TABLE 009. OXIDIZED REGENERATED CELLULOSE BASED MARKET OVERVIEW (2016-2028)
TABLE 010. GELATIN BASED MARKET OVERVIEW (2016-2028)
TABLE 011. COLLAGEN BASED HEMOSTAT MARKET OVERVIEW (2016-2028)
TABLE 012. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 013. SURGICAL HEMOSTAT MARKET BY APPLICATION
TABLE 014. NEUROLOGICAL SURGERY MARKET OVERVIEW (2016-2028)
TABLE 015. CARDIOVASCULAR SURGERY MARKET OVERVIEW (2016-2028)
TABLE 016. RECONSTRUCTIVE SURGERY MARKET OVERVIEW (2016-2028)
TABLE 017. GYNECOLOGICAL SURGERY MARKET OVERVIEW (2016-2028)
TABLE 018. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 019. NORTH AMERICA SURGICAL HEMOSTAT MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 020. NORTH AMERICA SURGICAL HEMOSTAT MARKET, BY APPLICATION (2016-2028)
TABLE 021. N SURGICAL HEMOSTAT MARKET, BY COUNTRY (2016-2028)
TABLE 022. EUROPE SURGICAL HEMOSTAT MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 023. EUROPE SURGICAL HEMOSTAT MARKET, BY APPLICATION (2016-2028)
TABLE 024. SURGICAL HEMOSTAT MARKET, BY COUNTRY (2016-2028)
TABLE 025. ASIA PACIFIC SURGICAL HEMOSTAT MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 026. ASIA PACIFIC SURGICAL HEMOSTAT MARKET, BY APPLICATION (2016-2028)
TABLE 027. SURGICAL HEMOSTAT MARKET, BY COUNTRY (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA SURGICAL HEMOSTAT MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA SURGICAL HEMOSTAT MARKET, BY APPLICATION (2016-2028)
TABLE 030. SURGICAL HEMOSTAT MARKET, BY COUNTRY (2016-2028)
TABLE 031. SOUTH AMERICA SURGICAL HEMOSTAT MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 032. SOUTH AMERICA SURGICAL HEMOSTAT MARKET, BY APPLICATION (2016-2028)
TABLE 033. SURGICAL HEMOSTAT MARKET, BY COUNTRY (2016-2028)
TABLE 034. CR BARD INC. (UNITED STATES): SNAPSHOT
TABLE 035. CR BARD INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 036. CR BARD INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 037. CR BARD INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. B. BRAUN MELSUNGEN AG (GERMANY): SNAPSHOT
TABLE 038. B. BRAUN MELSUNGEN AG (GERMANY): BUSINESS PERFORMANCE
TABLE 039. B. BRAUN MELSUNGEN AG (GERMANY): PRODUCT PORTFOLIO
TABLE 040. B. BRAUN MELSUNGEN AG (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. BAXTER INTERNATIONAL INC. (UNITED STATES): SNAPSHOT
TABLE 041. BAXTER INTERNATIONAL INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 042. BAXTER INTERNATIONAL INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 043. BAXTER INTERNATIONAL INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. INTEGRA LIFESCIENCES (UNITED STATES): SNAPSHOT
TABLE 044. INTEGRA LIFESCIENCES (UNITED STATES): BUSINESS PERFORMANCE
TABLE 045. INTEGRA LIFESCIENCES (UNITED STATES): PRODUCT PORTFOLIO
TABLE 046. INTEGRA LIFESCIENCES (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. MARINE POLYMER TECHNOLOGIES INC. (UNITED STATES): SNAPSHOT
TABLE 047. MARINE POLYMER TECHNOLOGIES INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 048. MARINE POLYMER TECHNOLOGIES INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 049. MARINE POLYMER TECHNOLOGIES INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. TELEFLEX (UNITED STATES): SNAPSHOT
TABLE 050. TELEFLEX (UNITED STATES): BUSINESS PERFORMANCE
TABLE 051. TELEFLEX (UNITED STATES): PRODUCT PORTFOLIO
TABLE 052. TELEFLEX (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. ETHICON INC. (UNITED STATES): SNAPSHOT
TABLE 053. ETHICON INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 054. ETHICON INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 055. ETHICON INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. PFIZER INC. (UNITED STATES): SNAPSHOT
TABLE 056. PFIZER INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 057. PFIZER INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 058. PFIZER INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. Z-MEDICA LLC (UNITED STATES): SNAPSHOT
TABLE 059. Z-MEDICA LLC (UNITED STATES): BUSINESS PERFORMANCE
TABLE 060. Z-MEDICA LLC (UNITED STATES): PRODUCT PORTFOLIO
TABLE 061. Z-MEDICA LLC (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. GELITA MEDICAL GMBH (GERMANY): SNAPSHOT
TABLE 062. GELITA MEDICAL GMBH (GERMANY): BUSINESS PERFORMANCE
TABLE 063. GELITA MEDICAL GMBH (GERMANY): PRODUCT PORTFOLIO
TABLE 064. GELITA MEDICAL GMBH (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. ANIKA THERAPEUTICS INC. (UNITED STATES): SNAPSHOT
TABLE 065. ANIKA THERAPEUTICS INC. (UNITED STATES): BUSINESS PERFORMANCE
TABLE 066. ANIKA THERAPEUTICS INC. (UNITED STATES): PRODUCT PORTFOLIO
TABLE 067. ANIKA THERAPEUTICS INC. (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. STRYKER (UNITED STATES): SNAPSHOT
TABLE 068. STRYKER (UNITED STATES): BUSINESS PERFORMANCE
TABLE 069. STRYKER (UNITED STATES): PRODUCT PORTFOLIO
TABLE 070. STRYKER (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. INTEGRA LIFESCIENCES CORPORATION (UNITED STATES): SNAPSHOT
TABLE 071. INTEGRA LIFESCIENCES CORPORATION (UNITED STATES): BUSINESS PERFORMANCE
TABLE 072. INTEGRA LIFESCIENCES CORPORATION (UNITED STATES): PRODUCT PORTFOLIO
TABLE 073. INTEGRA LIFESCIENCES CORPORATION (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 074. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 075. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 076. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SURGICAL HEMOSTAT MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SURGICAL HEMOSTAT MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. THROMBIN BASED MARKET OVERVIEW (2016-2028)
FIGURE 013. OXIDIZED REGENERATED CELLULOSE BASED MARKET OVERVIEW (2016-2028)
FIGURE 014. GELATIN BASED MARKET OVERVIEW (2016-2028)
FIGURE 015. COLLAGEN BASED HEMOSTAT MARKET OVERVIEW (2016-2028)
FIGURE 016. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 017. SURGICAL HEMOSTAT MARKET OVERVIEW BY APPLICATION
FIGURE 018. NEUROLOGICAL SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 019. CARDIOVASCULAR SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 020. RECONSTRUCTIVE SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 021. GYNECOLOGICAL SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 022. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 023. NORTH AMERICA SURGICAL HEMOSTAT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. EUROPE SURGICAL HEMOSTAT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. ASIA PACIFIC SURGICAL HEMOSTAT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. MIDDLE EAST & AFRICA SURGICAL HEMOSTAT MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. SOUTH AMERICA SURGICAL HEMOSTAT MARKET OVERVIEW BY COUNTRY (2016-2028)